av/celldex-therapeutics--big.svg

NASDAQ:CLDX

Celldex

  • Stock

USD

Last Close

39.94

17/05 20:00

Market Cap

2.00B

Beta: 2.11

Volume Today

438.32K

Avg: 647.39K

PE Ratio

−15.31

PFCF: −20.78

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.01
-
0.01
22.08%
0.02
12.27%
0.02
9.05%
0.04
128.08%
0.06
51.62%
0.03
52.52%
0.03
8.22%
0.01
66.75%
0.01
36.12%
0.01
121.22%
cash conversion cycle
-307.35
-
-183.86
-
cash per share
56.97
-
33.73
40.79%
44.80
32.82%
28.04
37.42%
16.27
41.97%
9.00
44.65%
4.44
50.71%
6.56
47.80%
9.52
45.18%
6.50
31.70%
8.70
33.83%
company equity multiplier
1.09
-
1.17
7.96%
1.16
0.69%
1.44
24.12%
1.34
7.55%
1.26
5.95%
1.31
4.10%
1.13
13.84%
1.06
5.90%
1.08
2.01%
1.08
0.33%
days of inventory outstanding
days of payables outstanding
350.77
-
423.97
-
days of sales outstanding
43.42
-
43.46
0.11%
64.61
48.65%
95.96
48.52%
53.85
43.88%
121.00
124.71%
103.69
14.31%
88.67
14.49%
13.50
84.78%
53.74
298.10%
240.12
346.85%
dividend yield
ebit per revenue
-19.81
-
-34.14
72.34%
-23.64
30.76%
-19.59
17.14%
-9.54
51.31%
-16.40
71.98%
-15.40
6.09%
-8.54
44.55%
-15.32
79.35%
-48.89
219.17%
-20.64
57.79%
ebt per ebit
1.00
-
0.96
3.68%
0.98
1.81%
0.97
1.52%
0.97
0.17%
0.97
0.62%
0.92
4.82%
0.96
4.05%
0.99
3.21%
0.97
1.83%
1.00
2.15%
effective tax rate
0.01
-
0.04
266.82%
0.02
49.98%
0.07
270.35%
0.21
203.28%
0.01
97.57%
0.01
97.54%
0.02
92.53%
0.00
83.24%
-0.09
3,001.34%
enterprise value multiple
-22.45
-
-13.23
41.07%
-11.11
16.01%
-2.33
79.07%
-3.45
48.39%
-18.18
426.77%
-0.43
97.66%
-12.54
2,844.01%
-23.99
91.29%
-20.27
15.51%
-13.59
32.95%
fixed asset turnover
0.41
-
0.34
17.42%
0.48
40.47%
0.51
7.58%
1.23
138.84%
1.56
27.04%
0.89
43.21%
1.94
119.37%
1.31
32.64%
0.63
51.97%
1.04
64.87%
free cash flow per share
-13.52
-
-17.36
28.44%
-16.04
7.62%
-17.11
6.67%
-11.87
30.62%
-7.28
38.64%
-3.25
55.38%
-1.42
56.44%
-1.45
2.43%
-2.25
55.27%
-2.25
0.03%
gross profit margin
0.43
-
1
131.34%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
0.56
43.70%
interest coverage
-87.86
-
-7.61
-
-1.04
86.39%
39.61
-
inventory turnover
long term debt to capitalization
-0.08
-
0.02
-
0.01
43.08%
0.00
69.76%
0.01
155.56%
0.00
72.59%
net income per ebt
1
-
1
0%
1
0%
1
0%
0.79
20.70%
0.99
25.47%
0.99
0.49%
0.98
0.93%
1.00
1.62%
1.09
9.66%
1
8.52%
net profit margin
-19.84
-
-32.93
65.99%
-23.21
29.51%
-18.94
18.40%
-7.30
61.46%
-15.85
117.12%
-14.10
11.06%
-8.06
42.84%
-15.16
88.12%
-52.09
243.61%
-20.55
60.56%
operating cash flow per share
-12.72
-
-17.04
33.90%
-15.28
10.29%
-16.70
9.27%
-11.66
30.18%
-7.21
38.21%
-3.20
55.59%
-1.36
57.39%
-1.42
4.23%
-2.21
55.71%
-2.21
0.10%
operating cycle
43.42
-
240.12
-
operating profit margin
-19.81
-
-34.14
72.34%
-23.64
30.76%
-19.59
17.14%
-9.54
51.31%
-16.40
71.98%
-15.40
6.09%
-8.54
44.55%
-15.32
79.35%
-48.89
219.17%
-20.64
57.79%
payables turnover
1.04
-
0.86
-
pretax profit margin
-19.84
-
-32.93
65.99%
-23.21
29.51%
-18.94
18.40%
-9.21
51.39%
-15.93
73.05%
-14.24
10.62%
-8.22
42.30%
-15.21
85.11%
-47.66
213.34%
-20.55
56.88%
price fair value
6.04
-
7.71
27.63%
5.25
31.95%
1.35
74.19%
1.54
14.07%
0.25
83.65%
0.34
36.26%
2.48
620.93%
3.95
59.21%
6.41
62.23%
4.48
30.11%
receivables turnover
8.41
-
8.40
0.10%
5.65
32.73%
3.80
32.67%
6.78
78.19%
3.02
55.50%
3.52
16.70%
4.12
16.94%
27.04
556.88%
6.79
74.88%
1.52
77.62%
return on assets
-0.23
-
-0.48
102.64%
-0.38
20.86%
-0.34
11.02%
-0.29
12.09%
-0.97
229.20%
-0.41
57.77%
-0.25
38.14%
-0.16
37.44%
-0.35
119.51%
-0.30
12.74%
return on capital employed
-0.25
-
-0.55
119.75%
-0.42
23.05%
-0.38
9.42%
-0.42
10.57%
-1.09
158.78%
-0.49
54.73%
-0.29
42.19%
-0.17
41.79%
-0.34
107.25%
-0.33
5.21%
return on equity
-0.26
-
-0.56
118.77%
-0.44
21.41%
-0.48
10.44%
-0.39
18.72%
-1.22
209.63%
-0.54
56.04%
-0.29
46.70%
-0.17
41.13%
-0.38
123.92%
-0.33
12.45%
total debt to capitalization
0.01
-
-0.06
609.07%
0.03
-
0.04
30.23%
0.04
6.36%
0.02
56.31%
0.01
55.98%
0.01
69.62%
0.01
51.79%

All numbers in USD (except ratios and percentages)